Two AI-lookalike audiences, scored separately against 34 other ingredient makers.
Gutsy brand and campaign intelligence. AI-lookalike audience reads, not survey data. Hover a chip for detail.
Ranks of 35 ingredient makers. Hover a name for what each audience buys on.
"…sterile corporate alliteration that reveals zero functional ingredient details…"CPG Founder · Gutsy scoring rationale
"…allowing an R&D professional to immediately map their portfolio…"R&D Manager · Gutsy scoring rationale
Verdict: Healthy with R&D, Weak with Founders. Loved in the lab, not yet by the person who signs off.
Brand score 6.56 vs 5.17: a Founder-to-R&D gap of 1.39, the second-largest of 35.
Ranks among 35 ingredient makers. Hover any tile for the score and detail.
"…grandiose legacy boilerplate that offers no actionable insight…"
"…anchors the company in food science…"
Excerpts from Gutsy scoring rationales. Hover a quote for the implicit promise and moments of truth.
Scores out of 10, sorted by gap. Hover a dot for rank of 35, average and lowest subfactor. Not in Gutsy's dataset: Awareness, Relevance and Premium-ness.
Founder-to-R&D gap, second-largest of 35
Novonesis, GNT (EXBERRY), Oterra, Nexira, Axiom Foods, Corbion, Darling (Rousselot)
Ingredion #10 / #11 · SweeGen #11 / #23 · Roquette #14 / #13
Brand score per audience; dashed lines are 35-maker averages. Peer ranks: Founder / R&D.
"…an artificial sweetener clean-label founders deliberately formulate out of challenger products…"
"…corporate promises reflect actual application capability rather than unbacked marketing…"
Founder scores. Tate & Lyle sits below the 35-maker average on all four.
All seven beat the average on the first and third rows; 6 of 7 on concept ownership. A shared pattern, not shown to cause rank.
Rank of 35 per attribute (left is better). Portfolio clarity with R&D is a tie at #1, so Shared. Hover a row for evidence.
Delivery index per audience, never averaged across audiences. Hover a row for the friction, a cell for its signals.
"…misses the authentic, acute tension modern founders battle…"
Neither film publishes results, so effectiveness evidence sits near zero: unproven, not failed. Hover a bar for rank and detail.
Mission concreteness, Founder vs R&D
Founder Innovation language (joint #23) despite 958 patents
recorded headlines on the pending Ingredion acquisition; Founder Leadership press signal 4.10
Stated identity verbatim from tateandlyle.com. Hover a card line for the quotes behind it.
Continuity of supply and technical service while the acquisition is pending. Leadership stability 3.90 / 4.20
Carry the SBTi-validated targets into the sustainability line. Founder Unverifiable claims 7.50
One line a founder can put on pack, backed. Founder Positioning uniqueness 3.60
Re-cut the Sensation story for clean-label challengers. Founder Campaign score 3.50
Do not trade the portfolio map for softer copy. R&D Clarity #2
Hover an action title for owner, confidence and target.
Gutsy intelligence pipeline. Hover any chip for detail.